Hypomagnesemia as a Risk Factor and Accelerator for Vascular Aging in Diabetes Mellitus and Chronic Kidney Disease

The age-old axiom that one is as old as his or her vessels are, calls for ongoing critical re-examination of modifiable risk factors of accelerated vascular ageing in chronic kidney diseases. Attempts to modulate vascular risk with cholesterol-lowering agents have largely failed in advanced chronic kidney disease (CKD). In addition to nitrogen waste products, many pathological biochemical processes also play a role in vascular calcification in chronic kidney damage. Magnesium, a cation vital for the body, may substantially reduce cardiovascular diseases’ risk and progression. This narrative review aimed to address the relationship between hypomagnesemia and vascular calcification, which promotes further cardiovascular complications in diabetes, aging, and CKD. Articles with predefined keywords were searched for in the PubMed and Google Scholar databases with specific inclusion and exclusion criteria. We hypothesized that a decrease in serum magnesium levels contributes to increased vascular calcification and thereby increases cardiovascular mortality. In summary, based on existing evidence in the literature, it appears that simple and inexpensive oral magnesium supplementation may reduce the cardiovascular mortality of patients who are already severely affected by such diseases; in this context, the concept of ‘normal’ vs. ‘ideal’ serum magnesium levels should be carefully re-examined.

[1]  Wei-Han Pan,et al.  Vascular calcification: Molecular mechanisms and therapeutic interventions , 2023, MedComm.

[2]  S. Hsieh,et al.  Panax notoginseng Suppresses Bone Morphogenetic Protein-2 Expression in EA.hy926 Endothelial Cells by Inhibiting the Noncanonical NF-κB and Wnt/β-Catenin Signaling Pathways , 2022, Plants.

[3]  O. K. Duru,et al.  Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020. , 2022, The New England journal of medicine.

[4]  R. Sundaramurthy,et al.  Association of Serum Magnesium with Insulin Indices in Patients with Type 2 Diabetes Mellitus. , 2022, Maedica.

[5]  Hongli Jiang,et al.  Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study , 2022, Renal failure.

[6]  Isamu Mizote,et al.  Preoperative hypomagnesemia as a possible predictive factor for postoperative increase of transvalvular pressure gradient in hemodialysis patients treated with transcatheter aortic valve implantation , 2022, Renal failure.

[7]  N. Soltani,et al.  The Therapeutic Effects of Magnesium in Insulin Secretion and Insulin Resistance , 2022, Advanced biomedical research.

[8]  B. Yi,et al.  Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis , 2022, Renal failure.

[9]  Z. Massy,et al.  Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings? , 2022, Toxins.

[10]  N. Toussaint,et al.  Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials , 2022, Journal of the American Society of Nephrology : JASN.

[11]  Y. Sakaguchi The emerging role of magnesium in CKD , 2022, Clinical and Experimental Nephrology.

[12]  A. Morgan,et al.  A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives , 2021, Advances in Therapy.

[13]  M. Barbagallo,et al.  The relevance of magnesium homeostasis in COVID-19 , 2021, European Journal of Nutrition.

[14]  L. Yao,et al.  Effect of Magnesium Supplementation on Chronic Kidney Disease-Mineral and Bone Disorder in Hemodialysis Patients: A Meta-Analysis of Randomized Controlled Trials. , 2021, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[15]  Rui Shi,et al.  Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease , 2021, Renal failure.

[16]  E. Hoorn,et al.  An overview of diagnosis and management of drug‐induced hypomagnesemia , 2021, Pharmacology research & perspectives.

[17]  M. Ando,et al.  Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5 , 2021, PLoS ONE.

[18]  L. Renders,et al.  Estimating serum‐ionized magnesium concentration in hemodialysis patients , 2021, Hemodialysis international. International Symposium on Home Hemodialysis.

[19]  A. Stănescu,et al.  Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review , 2021, Nutrients.

[20]  T. Stompór,et al.  Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization , 2021, Toxins.

[21]  J. Wetzels,et al.  Low plasma magnesium concentration and future abdominal aortic calcifications in moderate chronic kidney disease , 2021, BMC Nephrology.

[22]  B. Urquhart,et al.  Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets , 2021, Toxins.

[23]  M. Barbagallo,et al.  Magnesium in Aging, Health and Diseases , 2021, Nutrients.

[24]  Shixiang Wang,et al.  Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis , 2021, Renal failure.

[25]  M. Vervloet,et al.  The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis. , 2020, Clinical nutrition.

[26]  Shih-Hua Lin,et al.  Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins , 2020, Toxins.

[27]  J. Muñoz-Castañeda,et al.  The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities , 2020, Frontiers in Cell and Developmental Biology.

[28]  Tingting Wang,et al.  Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1-4 patients. , 2020, Clinical nutrition.

[29]  L. Troncone,et al.  The role of bone morphogenetic protein signaling in vascular calcification. , 2020, Bone.

[30]  M. Puerta,et al.  Hypomagnesaemia in haemodialysis is associated with increased mortality risk: its relationship with dialysis fluid. , 2020, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[31]  M. Ardalan,et al.  Vascular Calcification: An Important Understanding in Nephrology , 2020, Vascular health and risk management.

[32]  M. Mcmahon,et al.  Magnesium: The overlooked electrolyte in blood cancers? , 2020, Blood reviews.

[33]  D. Freimark,et al.  Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation. , 2020, The American journal of cardiology.

[34]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[35]  Z. Diao,et al.  Genome-wide identification of lncRNAs and mRNAs differentially expressed in human vascular smooth muscle cells stimulated by high phosphorus , 2020, Renal failure.

[36]  D. Haffner,et al.  CKD-MBD post kidney transplantation , 2019, Pediatric Nephrology.

[37]  H. Morgenstern,et al.  US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  C. Ferreira,et al.  Case report: extreme coronary calcifications and hypomagnesemia in a patient with a 17q12 deletion involving HNF1B , 2019, BMC Nephrology.

[39]  Mami Kikuchi,et al.  Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients , 2019, Renal failure.

[40]  N. Vallianou,et al.  Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship? , 2018, Current cardiology reviews.

[41]  M. Lenardo,et al.  Mg 2+ regulation of kinase signaling and immune function , 2019 .

[42]  A. Corsonello,et al.  Magnesium and elderly patient: the explored paths and the ones to be explored: a review. , 2019, Magnesium research.

[43]  Xin-Yuan Sun,et al.  Magnesium Citrate Protects Against Vascular Calcification in an Adenine-induced Chronic Renal Failure Rat Model , 2018, Journal of cardiovascular pharmacology.

[44]  C. Ohyama,et al.  Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis , 2018, PloS one.

[45]  K. Campbell,et al.  Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  M. Horie,et al.  Serum magnesium, phosphorus, and calcium levels and subclinical calcific aortic valve disease: A population-based study. , 2018, Atherosclerosis.

[47]  Marcello Tonelli,et al.  The global burden of kidney disease and the sustainable development goals , 2018, Bulletin of the World Health Organization.

[48]  Guy Paré,et al.  Transparency in literature reviews: an assessment of reporting practices across review types and genres in top IS journals , 2017, Eur. J. Inf. Syst..

[49]  D. Volkert,et al.  [Refeeding syndrome in geriatric patients : A frequently overlooked complication]. , 2018, Zeitschrift fur Gerontologie und Geriatrie.

[50]  Z. Massy,et al.  Magnesium supplementation: A consideration in dialysis patients , 2018, Seminars in dialysis.

[51]  M. Tapolyai,et al.  Peritoneal dialysis: The unique features by compartmental delivery of renal replacement therapy. , 2017, Medical hypotheses.

[52]  C. Shanahan,et al.  Magnesium Counteracts Vascular Calcification: Passive Interference or Active Modulation? , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[53]  M. Shechter,et al.  The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. , 2017, The American journal of clinical nutrition.

[54]  Tianwen Lai,et al.  Does Hypomagnesemia Impact on the Outcome of Patients Admitted to the Intensive Care Unit? A Systematic Review and Meta-Analysis , 2017, Shock.

[55]  S. Kitsiou Methods for Literature Reviews , 2017 .

[56]  X. Fang,et al.  Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies , 2016, BMC Medicine.

[57]  A. Sahebkar,et al.  A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. , 2016, Pharmacological research.

[58]  D. S̆timac,et al.  Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis? , 2016, European journal of internal medicine.

[59]  A. Negri,et al.  Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients , 2016, Clinical kidney journal.

[60]  G. Trajkovic,et al.  Is low magnesium a clue to arteriovenous fistula complications in hemodialysis? , 2016, International Urology and Nephrology.

[61]  J. Heaf Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient , 2015, Peritoneal Dialysis International.

[62]  Ahsan Alam,et al.  The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study , 2015, BMC Nephrology.

[63]  S. Erickson,et al.  Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies , 2015, Renal failure.

[64]  A. Garg,et al.  Worldwide access to treatment for end-stage kidney disease: a systematic review , 2015, The Lancet.

[65]  J. Hoenderop,et al.  Magnesium in man: implications for health and disease. , 2015, Physiological reviews.

[66]  Aníbal Ferreira,et al.  Lower Serum Magnesium Is Associated with Cardiovascular Risk Factors and Mortality in Haemodialysis Patients , 2015, Blood Purification.

[67]  J. Floege Magnesium in CKD: more than a calcification inhibitor? , 2014, Journal of Nephrology.

[68]  D. Kolte,et al.  Role of Magnesium in Cardiovascular Diseases , 2014, Cardiology in review.

[69]  Harold I Feldman,et al.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[70]  W. März,et al.  Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. , 2014, Metabolism: clinical and experimental.

[71]  Johannes W. Dietrich,et al.  [Refeeding syndrome: a review of the literature]. , 2014, Zeitschrift fur Gastroenterologie.

[72]  N. Fujii,et al.  Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. , 2014, Kidney international.

[73]  Mariano Rodríguez,et al.  Magnesium - its role in CKD. , 2013, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[74]  Josef Coresh,et al.  Chronic kidney disease , 2012, The Lancet.

[75]  R. Mehrotra,et al.  Cardiovascular disease in chronic kidney disease , 2012 .

[76]  G. Remuzzi,et al.  The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. , 2011, Kidney international.

[77]  A. Romani Cellular magnesium homeostasis. , 2011, Archives of biochemistry and biophysics.

[78]  D. Spiegel Magnesium in Chronic Kidney Disease: Unanswered Questions , 2011, Blood Purification.

[79]  M. Sarnak,et al.  CORE CURRICULUM IN NEPHROLOGY Cardiovascular Disease and CKD: Core Curriculum 2010 , 2010 .

[80]  M. Inaba,et al.  Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. , 2007, Clinical nephrology.

[81]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[82]  J. D. de Lemos,et al.  Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice. , 2006, The American journal of the medical sciences.

[83]  A. Garg,et al.  Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.

[84]  J. Bargman,et al.  Relationship between Serum Magnesium, Parathyroid Hormone, and Vascular Calcification in Patients on Dialysis: A Literature Review , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[85]  O. Bermudez,et al.  What is refeeding syndrome? , 2004, Eating disorders.

[86]  H. Gruber,et al.  Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha. , 2004, The Journal of nutrition.

[87]  M. Barbagallo,et al.  Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. , 2003, Molecular aspects of medicine.

[88]  A. Garg,et al.  Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. , 2002, Kidney international.

[89]  T. Orchard Magnesium and type 2 diabetes mellitus. , 1999, Archives of internal medicine.

[90]  A. Folsom,et al.  Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. , 1999, Archives of internal medicine.

[91]  A. Folsom,et al.  Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. , 1998, American heart journal.

[92]  D. Serur,et al.  Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[93]  Mark N. Gomez Magnesium and Cardiovascular Disease , 1998, Anesthesiology.

[94]  David C. Murray,et al.  The prognostic importance of left ventricular geometry in uremic cardiomyopathy. , 1995, Journal of the American Society of Nephrology : JASN.

[95]  D. Banks,et al.  Pulmonary response to hyperoxia: effects of magnesium. , 1994, Environmental health perspectives.

[96]  R. Whang,et al.  Magnesium Homeostasis and Clinical Disorders of Magnesium Deficiency , 1994, The Annals of pharmacotherapy.

[97]  M. Gonella,et al.  Magnesium status in chronically haemodialyzed patients: the role of dialysate magnesium concentration. , 1989, Magnesium research.

[98]  S. Chrysant,et al.  Hemodynamic and metabolic effects of hypomagnesemia in spontaneously hypertensive rats. , 1988, Cardiology.

[99]  C. Christiansen,et al.  Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis , 1982, European journal of clinical investigation.

[100]  S. Massry,et al.  Hypomagnesemia and Hypermagnesemia , 1984 .

[101]  H. G. Lloyd-Thomas Diuretics , 1959, Postgraduate medical journal.